CoChat

Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia

Open access
Argibay, Bárbara, Trekker, Jesse, Himmelreich, Uwe, Beiras, Andrés, Topete, Antonio, Taboada, Pablo, Pérez-Mato, María, Vieites-Prado, Alba, Iglesias-Rey, Ramón, Rivas, José, Planas, Anna M., Sobrino, Tomás, Castillo, José, Campos, Francisco · 2017 · Scientific Reports
Cited by 104

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Mesenchymal stem cells (MSCs) are a promising clinical therapy for ischemic stroke. However, critical parameters, such as the most effective administration route, remain unclear. Intravenous (i.v.) and intraarterial (i.a.) delivery routes have yielded varied outcomes across studies, potentially due to the unknown MSCs distribution. We investigated whether MSCs reached the brain following i.a. or i.v. administration after transient cerebral ischemia in rats, and evaluated the therapeutic effects of both routes. MSCs were labeled with dextran-coated superparamagnetic nanoparticles for magnetic resonance imaging (MRI) cell tracking, transmission electron microscopy and immunohistological analysis. MSCs were found in the brain following i.a. but not i.v. administration. However, the i.a. route increased the risk of cerebral lesions and did not improve functional recovery. The i.v. delivery is safe but MCS do not reach the brain tissue, implying that treatment benefits observed for this route are not attributable to brain MCS engrafting after stroke.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep40758

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 88

  1. Howard, G. & Goff, D. C. Population shifts and the future of stroke: forecasts of the future burden of stroke. Ann N Y Acad Sci 1268, 14–20 (2012). · DOI · Paper page
  2. Paul, G. & Anisimov, S. V. The secretome of mesenchymal stem cells: potential implications for neuroregeneration. Biochimie 95, 2246–2256 (2013). · DOI
  3. Wislet-Gendebien, S. et al. Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem Cells 23, 392–402 (2005). · DOI · Paper page
  4. Brazelton, T. R., Rossi, F. M., Keshet, G. I. & Blau, H. M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290, 1775–1779 (2000). · DOI · Paper page
  5. Kopen, G. C., Prockop, D. J. & Phinney, D. G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 96, 10711–10716 (1999). · DOI · Paper page
  6. Mezey, E., Chandross, K. J., Harta, G., Maki, R. A. & McKercher, S. R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290, 1779–1782 (2000). · DOI · Paper page
  7. Chen, J. et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73, 778–786 (2003). · DOI · Paper page
  8. Li, Y. et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59, 514–523 (2002). · DOI · Paper page
  9. Li, Y. et al. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 20, 1311–1319 (2000). · DOI · Paper page
  10. Shen, L. H. et al. Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience 137, 393–399 (2006). · DOI · Paper page
  11. Borlongan, C. V. et al. Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res 1010, 108–116 (2004). · DOI · Paper page
  12. Chen, J., Li, Y., Wang, L., Lu, M. & Chopp, M. Caspase inhibition by Z-VAD increases the survival of grafted bone marrow cells and improves functional outcome after MCAo in rats. J Neurol Sci 199, 17–24 (2002). · doi:10.1016/s0022-510x(02)00075-8
  13. Chopp, M. & Li, Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol 1, 92–100 (2002). · DOI · Paper page
  14. Chen, J. et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32, 2682–2688 (2001). · DOI · Paper page
  15. Li, X. & Zuo, P. Effects of Abeta25-35 on neurogenesis in the adult mouse subventricular zone and dentate gyrus. Neurol Res 27, 218–222 (2005). · DOI
  16. Nakano-Doi, A. et al. Bone marrow mononuclear cells promote proliferation of endogenous neural stem cells through vascular niches after cerebral infarction. Stem Cells 28, 1292–1302 (2010). · DOI · Paper page
  17. Giraldi-Guimardes, A., Rezende-Lima, M., Bruno, F. P. & Mendez-Otero, R. Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats. Brain Res 1266, 108–120 (2009). · DOI
  18. de Vasconcelos Dos Santos, A. et al. Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats. Brain Res 1306, 149–158 (2010). · DOI
  19. Brenneman, M. et al. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab 30, 140–149 (2010). · DOI · Paper page
  20. Jolkkonen, J. & Walczak, P. Cell-Based Therapies in Stroke (Springer, 2013). · doi:10.1007/978-3-7091-1175-8
  21. Walczak, P. et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 39, 1569–1574 (2008). · DOI · Paper page
  22. Li, Y., Chen, J., Wang, L., Lu, M. & Chopp, M. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56, 1666–1672 (2001). · DOI · Paper page
  23. Keimpema, E. et al. Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats. Neuropathol Appl Neurobiol 35, 89–102 (2009). · DOI
  24. Sharifi, S. et al. Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging. Contrast Media Mol Imaging 10, 329–355 (2015). · DOI
  25. Khalkhali, M. et al. The impact of polymer coatings on magnetite nanoparticles performance as MRI contrast agents: a comparative study. Daru 23, 45 (2015). · DOI
  26. Bautista, M. C., Bomati-Miguel, O., del Puerto Morales, M., Serna, C. J. & Veintemillas-Verdaguer, S. Surface characterisation of dextran-coated iron oxide nanoparticles prepared by laser pyrolysis and coprecipitation. Journal of Magnetism and Magnetic Materials 293, 20–27 (2005). · DOI · Paper page
  27. Easo, S. L. & Mohanan, P. V. Dextran stabilized iron oxide nanoparticles: synthesis, characterization and in vitro studies. Carbohydr Polym 92, 726–732 (2013). · DOI
  28. Barker, R. A., Jain, M., Armstrong, R. J. & Caldwell, M. A. Stem cells and neurological disease. J Neurol Neurosurg Psychiatry 74, 553–557 (2003). · DOI
  29. Gage, F. H., Ray, J. & Fisher, L. J. Isolation, characterization, and use of stem cells from the CNS. Annu Rev Neurosci 18, 159–192 (1995). · DOI · Paper page
  30. Sobrino, T., Campos, F. & Castillo, J. Cellular Therapy for Stroke and CNS Injuries 1 edn, 109–123 (Springer International Publishing, 2015). · DOI
  31. Andreas, K. et al. Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking. Biomaterials 33, 4515–4525 (2012). · DOI · Paper page
  32. Frangioni, J. V. & Hajjar, R. J. In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 110, 3378–3383 (2004). · DOI · Paper page
  33. Rogers, W. J., Meyer, C. H. & Kramer, C. M. Technology insight: in vivo cell tracking by use of MRI. Nature clinical practice. Cardiovascular medicine 3, 554–562 (2006). · DOI · Paper page
  34. Kurtz, A. Mesenchymal stem cell delivery routes and fate. International journal of stem cells 1, 1–7 (2008). · DOI · Paper page
  35. Fukuda, Y. et al. Intra-arterial transplantation of low-dose stem cells provides functional recovery without adverse effects after stroke. Cellular and molecular neurobiology 35, 399–406 (2015). · DOI
  36. Karlupia, N., Manley, N. C., Prasad, K., Schafer, R. & Steinberg, G. K. Intraarterial transplantation of human umbilical cord blood mononuclear cells is more efficacious and safer compared with umbilical cord mesenchymal stromal cells in a rodent stroke model. Stem Cell Res Ther 5, 45 (2014). · DOI
  37. Lu, S. S. et al. In vivo MR imaging of intraarterially delivered magnetically labeled mesenchymal stem cells in a canine stroke model. PLoS One 8, e54963 (2013). · DOI
  38. Li, L. et al. Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J Cereb Blood Flow Metab 30, 653–662 (2010). · DOI · Paper page
  39. Tarulli, E. et al. Effectiveness of micron-sized superparamagnetic iron oxide particles as markers for detection of migration of bone marrow-derived mesenchymal stromal cells in a stroke model. J Magn Reson Imaging 37, 1409–1418 (2013). · DOI
  40. Vasconcelos-dos-Santos, A. et al. Intravenous and intra-arterial administration of bone marrow mononuclear cells after focal cerebral ischemia: Is there a difference in biodistribution and efficacy? Stem Cell Res 9, 1–8 (2012). · DOI
  41. Gutierrez-Fernandez, M. et al. Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats. Neuroscience 175, 394–405 (2011). · DOI
  42. Byun, J. S. et al. Engraftment of human mesenchymal stem cells in a rat photothrombotic cerebral infarction model: comparison of intra-arterial and intravenous infusion using MRI and histological analysis. J Korean Neurosurg Soc 54, 467–476 (2013). · DOI
  43. Bulte, J. W. & Kraitchman, D. L. Monitoring cell therapy using iron oxide MR contrast agents. Current pharmaceutical biotechnology 5, 567–584 (2004). · DOI · Paper page
  44. Mascolo, M., Pei, Y. & Ring, T. Room Temperature Co-Precipitation Synthesis of Magnetite Nanoparticles in a Large pH Window with Different Bases. Materials 6, 5549 (2013). · DOI · Paper page
  45. Pardoe, H., Chua-anusorn, W. St., Pierre, T. G. & Dobson, J. Structural and magnetic properties of nanoscale iron oxide particles synthesized in the presence of dextran or polyvinyl alcohol. Journal of Magnetism and Magnetic Materials 225, 41–46 (2001). · DOI · Paper page
  46. Wang, Y. X. Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. Quant Imaging Med Surg 1, 35–40 (2011).
  47. Park, J. H. et al. Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging. Adv Mater 20, 1630–1635 (2008). · DOI · Paper page
  48. Simberg, D. et al. Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials 30, 3926–3933 (2009). · DOI · Paper page
  49. Chertok, B. et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 29, 487–496 (2008). · DOI · Paper page
  50. Chen, B., Wu, W. & Wang, X. Magnetic iron oxide nanoparticles for tumor-targeted therapy. Current cancer drug targets 11, 184–189 (2011). · doi:10.2174/156800911794328475
  51. Kim, D. Y. et al. Effects of the Surface Charge of Stem Cell Membranes and DNA/Polyethyleneimine Nanocomplexes on Gene Transfection Efficiency. Journal of Biomedical Nanotechnology 11, 522–530 (2015). · doi:10.1166/jbn.2015.2060
  52. Arbab, A. S. et al. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging 3, 24–32 (2004). · doi:10.1162/153535004773861697 · Paper page
  53. Yu, M. X., Chen, W. L., Zhou, Q. & Gao, P. Study on ASTC-a-1 cells labeled with superparamagnetic iron oxide and its magnetic resonance imaging. Exp Biol Med (Maywood) 235, 1053–1061 (2010). · doi:10.1258/ebm.2010.010058
  54. Trekker, J. et al. Sensitive in vivo cell detection using size-optimized superparamagnetic nanoparticles. Biomaterials 35, 1627–1635 (2014). · DOI
  55. Roeder, E. et al. Dose-response of superparamagnetic iron oxide labeling on mesenchymal stem cells chondrogenic differentiation: a multi-scale in vitro study. PLoS One 9, e98451 (2014). · DOI
  56. Struys, T. et al. Magnetic resonance imaging of human dental pulp stem cells in vitro and in vivo . Cell Transplant 22, 1813–1829 (2013). · DOI
  57. Ruehm, S. G., Corot, C., Vogt, P., Kolb, S. & Debatin, J. F. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103, 415–422 (2001). · DOI · Paper page
  58. Ketkar-Atre, A. et al. Variability in contrast agent uptake by different but similar stem cell types. Int J Nanomedicine 8, 4577–4591 (2013).
  59. Crabbe, A. et al. Effects of MRI contrast agents on the stem cell phenotype. Cell Transplant 19, 919–936 (2010). · DOI · Paper page
  60. Ma, S. et al. Immunobiology of mesenchymal stem cells. Cell Death Differ 21, 216–225 (2014). · DOI · Paper page
  61. Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315–317 (2006). · DOI · Paper page
  62. Boxall, S. A. & Jones, E. Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int 2012, 975871 (2012). · DOI · Paper page
  63. Chamberlain, G., Fox, J., Ashton, B. & Middleton, J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25, 2739–2749 (2007). · DOI · Paper page
  64. Jones, E. & McGonagle, D. Human bone marrow mesenchymal stem cells in vivo . Rheumatology 47, 126–131 (2008). · DOI · Paper page
  65. Lu, D. et al. Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury. J Neurotrauma 18, 813–819 (2001). · DOI · Paper page
  66. Guo, L. et al. A novel method for efficient delivery of stem cells to the ischemic brain. Stem Cell Res Ther 4, 116 (2013). · doi:10.1186/scrt327
  67. Riou, A. et al. MRI assessment of the intra-carotid route for macrophage delivery after transient cerebral ischemia. NMR Biomed 26, 115–123 (2013). · DOI
  68. Du, S. et al. Intra-arterial delivery of human bone marrow mesenchymal stem cells is a safe and effective way to treat cerebral ischemia in rats. Cell transplantation 23 Suppl 1, S73–82 (2014). · DOI · Paper page
  69. Mitkari, B. et al. Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats. Experimental neurology 239, 158–162 (2013). · DOI
  70. Ishizaka, S. et al. Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke. Stroke; a journal of cerebral circulation 44, 720–726 (2013). · DOI · Paper page
  71. Santillan, A. et al. Cannulation of the internal carotid artery in mice: a novel technique for intra-arterial delivery of therapeutics. Journal of neuroscience methods 222, 106–110 (2014). · DOI
  72. Fagan, S. C., Lapchak, P. A., Liebeskind, D. S., Ishrat, T. & Ergul, A. Recommendations for preclinical research in hemorrhagic transformation. Transl Stroke Res 4, 322–327, doi: 10.1007/s12975-012-0222-5 (2013). · DOI
  73. Janowski, M. et al. Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J Cereb Blood Flow Metab 33, 921–927 (2013). · DOI · Paper page
  74. Villalobos, V. et al. Ultrastructural changes of the olfactory bulb in manganese-treated mice. Biocell 33, 187–197 (2009). · DOI
  75. Liu, L. et al. From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? Stem Cells Int 2013, 435093 (2013).
  76. Schrepfer, S. et al. Stem cell transplantation: the lung barrier. Transplant Proc 39, 573–576 (2007). · DOI · Paper page
  77. Iihoshi, S., Honmou, O., Houkin, K., Hashi, K. & Kocsis, J. D. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res 1007, 1–9 (2004). · DOI · Paper page
  78. Zhang, L. et al. Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia. Stroke 42, 1437–1444 (2011). · DOI
  79. Zhang, L. et al. Intravenous administration of human umbilical tissue-derived cells improves neurological function in aged rats after embolic stroke. Cell Transplant (2012). · DOI
  80. Ramos-Cabrer, P., Justicia, C., Wiedermann, D. & Hoehn, M. Stem cell mediation of functional recovery after stroke in the rat. PLoS One 5, e12779 (2010). · DOI
  81. Suzuki, J. et al. Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model. Brain Res 1497, 15–22 (2013). · DOI
  82. Chopp, M. & Li, Y. Treatment of stroke and intracerebral hemorrhage with cellular and pharmacological restorative therapies. Acta Neurochir Suppl 105, 79–83 (2008). · DOI
  83. Choi, J. H. et al. Cell proliferation and neuroblast differentiation in the rat dentate gyrus after intrathecal treatment with adipose-derived mesenchymal stem cells. Cellular and molecular neurobiology 31, 1271–1280 (2011). · DOI
  84. Yoo, S. W. et al. Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model. Exp Mol Med 40, 387–397 (2008). · DOI · Paper page
  85. Chen, J. et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 92, 692–699 (2003). · DOI · Paper page
  86. Ankrum, J. & Karp, J. M. Mesenchymal stem cell therapy: Two steps forward, one step back. Trends in molecular medicine 16, 203–209 (2010). · DOI · Paper page
  87. Li, Y. & Chopp, M. Marrow stromal cell transplantation in stroke and traumatic brain injury. Neuroscience letters 456, 120–123 (2009). · DOI · Paper page
  88. Eckert, M. A. et al. Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke. J Cereb Blood Flow Metab 33, 1322–1334 (2013). · DOI

Cited by

See all 104

Metadata

Authors
Argibay, B., Trekker, J., Himmelreich, U., Beiras, A., Topete, A., Taboada, P., Pérez-Mato, M., Vieites-Prado, A., Iglesias-Rey, R., Rivas, J., Planas, A. M., Sobrino, T., Castillo, J., & Campos, F.
Venue
Scientific Reports
Published
2017-01-16
Volume
7
Issue
1
Pages
40758-40758
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2574930115
Cited by
104
References
9
FWCI
5.49
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia. https://app.cochat.ai/papers/10.1038/srep40758
The paper
Argibay, B., Trekker, J., Himmelreich, U., Beiras, A., Topete, A., Taboada, P., Pérez-Mato, M., Vieites-Prado, A., Iglesias-Rey, R., Rivas, J., Planas, A. M., Sobrino, T., Castillo, J., & Campos, F. (2017). Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia. Scientific Reports. https://doi.org/10.1038/srep40758

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.